文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症监护病房中的严重李斯特菌病:一项回顾性多中心研究

Severe listeriosis in intensive care units: insights from a retrospective multicentric study.
PubMed 文献 · Crit Care · 2025-05-19
一句话结论ICU李斯特菌病患者ICU死亡率为25%,神经李斯特菌病入院时格拉斯哥昏迷量表评分每降低1分与死亡率升高相关(OR 1.22)。

这项回顾性多中心研究纳入法国23家医院10年间110例ICU培养确诊李斯特菌感染患者,中位年龄68岁,71%免疫抑制,多数有神经系统受累。58%需有创机械通气,44%需血管活性药物支持,ICU死亡率为25%,院内死亡率为32%。在神经李斯特菌病患者中,入院时格拉斯哥昏迷量表评分每降低1分与死亡率升高相关(OR 1.22;95%CI 1.05-1.45;p=0.009),脑脊液蛋白水平升高亦与死亡率升高相关(OR 1.56;95%CI 1.15-2.41;p=0.028)。激素使用与死亡率降低无显著关联(OR 0.30;95%CI 0.07-1.05;p=0.076)。

要点

  • ICU李斯特菌病患者ICU死亡率为25%,院内死亡率为32%,中位年龄68岁,71%免疫抑制。
  • 58%需有创机械通气,44%需血管活性药物支持,反映器官支持需求频繁。
  • 神经李斯特菌病患者入院时格拉斯哥昏迷量表评分每降低1分,死亡率升高(OR 1.22;95%CI 1.05-1.45;p=0.009)。
  • 神经李斯特菌病患者脑脊液蛋白水平升高与死亡率升高相关(OR 1.56;95%CI 1.15-2.41;p=0.028)。
  • 激素使用与死亡率降低无显著关联(OR 0.30;95%CI 0.07-1.05;p=0.076),作者认为需进一步研究明确激素在神经李斯特菌病中的潜在作用。

适用人群与场景

  • 法国23家医院ICU中培养确诊李斯特菌感染的患者,中位年龄68岁,61%男性,71%免疫抑制,多数有神经系统受累。

研究设计与关键结果

  • 回顾性多中心研究,纳入法国23家医院10年间110例ICU培养确诊李斯特菌感染患者,主要终点为ICU死亡率。
  • ICU死亡率为25%,院内死亡率为32%;58%需有创机械通气,44%需血管活性药物支持。
  • 神经李斯特菌病患者中,入院时格拉斯哥昏迷量表评分每降低1分与死亡率升高相关(OR 1.22;95%CI 1.05-1.45;p=0.009)。
  • 神经李斯特菌病患者中,脑脊液蛋白水平升高与死亡率升高相关(OR 1.56;95%CI 1.15-2.41;p=0.028)。
  • 激素使用与死亡率降低无显著关联(OR 0.30;95%CI 0.07-1.05;p=0.076)。

证据类型、等级与局限

  • 证据类型:回顾性多中心研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,需进一步研究明确激素在神经李斯特菌病中的潜在作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Listeriosis is a rare but severe foodborne infection, particularly affecting immunocompromised individuals and older adults. Severe cases may lead to neurolisteriosis and sepsis, necessitating intensive care unit (ICU) admission. This study aims to analyze the demographic characteristics, clinical presentation, microbiological findings, treatments, and outcomes of critically ill patients with Listeria infections in the ICU.

METHODS: A retrospective multicenter study was conducted across 23 French hospitals over a 10-year period, including ICU patients with culture-confirmed Listeria monocytogenes infections. Data on demographics, comorbidities, ICU admission characteristics, biological and microbiological parameters, treatments, and outcomes were collected. The primary outcome was ICU mortality. A multivariable logistic regression model was used to identify factors associated with mortality in patients with neurological manifestations.

RESULTS: A total of 110 patients were included, with a median age of 68 years; 61% were male, and 71% were immunocompromised. Neurological involvement was present in most cases. Invasive mechanical ventilation was required in 58% of patients, and vasopressor support in 44%. ICU and in-hospital mortality rates were 25% and 32%, respectively. Among patients with neurolisteriosis, each 1-point decrease in Glasgow Coma Scale score at admission was associated with increased mortality (OR, 1.22; 95% CI 1.05-1.45; p = 0.009), as were higher cerebrospinal fluid (CSF) protein levels (OR, 1.56; 95% CI 1.15-2.41; p = 0.028). Steroid use was not significantly associated with reduced mortality (OR, 0.30; 95% CI 0.07-1.05; p = 0.076).

CONCLUSION: Listeriosis requiring ICU admission is associated with high morbidity and mortality, particularly in older and immunocompromised patients. The severity of these infections is reflected by the frequent need for organ support. Further research is needed to clarify the potential role of steroids in neurolisteriosis.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Villa A, Cour M, De Prost N, et al. Severe listeriosis in intensive care units: insights from a retrospective multicentric study. Crit Care. 2025. PMID: 40389987. doi:10.1186/s13054-025-05421-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。